2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

Saturday, December 12, 2026
05:30 p.m. - 07:30 p.m.
MCCNO - Hall F
Treatment Considerations, Drug Development, Biological Processes, Molecular Biology, Diseases, Bleeding and Clotting, Bleeding Disorders, Hemophilia, Infectious Diseases, Research, Fundamental Science, Translational Research, Study Population, Animal Model
PAPER

1268 Single-cell transcriptomic profiling reveals splenic immune cell alterations and ferroptosis activation in hemophilia A mice with FVIII inhibitors

Yingyu Chen, PhD, Yali Wang, MD2, Yawen Deng, MS3, Kehan Lin, MS4
1 Fujian Medical University Union Hospital, Fuzhou, Fujian, China
2 Fujian Medical University Union Hospital, Fuzhou, Fujian, China
3 Fujian Medical University Union Hospital, Fuzhou, Fujian, China
4 Fujian Medical University Union Hospital, Fuzhou, Fujian, China

Aims: The development of FVIII inhibitors represents a major and challenging complication in the management of hemophilia A (HA), though its underlying mechanism remains elusive. As the primary peripheral immune organ, the spleen demands closer scrutiny regarding how its immune microenvironment is altered following inhibitor emergence. Consequently, this study utilizes single-cell RNA-sequencing (scRNA-seq) to conduct a comprehensive analysis of the immune microenvironment within the spleens of HA mouse models with FVIII inhibitors, characterizing distinct cell subsets and identifying key molecular players.

Methods:An FVIII inhibitor mouse model was generated through repeated administration of recombinant human factor VIII (rhF8) to FVIIInull mice. Spleen samples from both the Inhibitor (n = 3) and Control (n = 3) groups were subsequently subjected to scRNA-seq. Subsequent data processing encompassed dimensionality reduction, clustering, and definitive cell annotation. Our investigative focus narrowed on B cells, macrophages, and the erythroid system, entailing differential expression analysis, GO/KEGG enrichment, cell-cell communication assessment, and pseudo-time-series analysis. Ferroptosis-related differentially expressed genes were systematically screened utilizing the FerrDb dataset, and the pivotal findings were rigorously validated via RT-qPCR, western blot, immunohistochemistry, and ELISA. The integrated metabolomic-transcriptomic analysis was further conducted.

Results: (1) Cellular atlas: Ten distinct cell clusters were identified. The inhibitor group demonstrated a marked increase in the proportions of erythroid progenitor cells and erythrocytes, accompanied by a notable decrease in B cells and macrophages. (2) Subpopulation analysis: Plasma cell proportions were elevated in the inhibitor group, with upregulated genes prominently enriched in protein folding and ribosome-related pathways. Macrophage populations significantly declined, their downregulated genes linked to JAK-STAT and TNF signaling pathways. Conversely, erythroid progenitors increased, displaying gene enrichment in oxidative stress and immune response pathways. (3) Intercellular communication and pseudo-time-series analysis: T cells, B cells, and plasmacytoid dendritic cells engaged in frequent interactions. Monocytes and macrophages functioned as critical signaling hubs. Pseudo-time-series analysis further revealed an accelerated differentiation trajectory for erythroid progenitors. (4) Ferroptosis activation and release of pro-inflammatory cytokines: Sixty differentially expressed ferroptosis-related genes were identified. Key hub genes tied to iron metabolism—Tfrc, Hmox1, Slc40a1, and Slc3a2—were significantly upregulated, while Trf was downregulated; these findings were confirmed at both mRNA and protein levels. Concurrently, plasma levels of pro-inflammatory cytokines (TNF-α, IL-1β, HMGB1, IL-6) were substantially elevated in the inhibitor mice. (5) Transcriptional and metabolic phenotypic reprogramming: GSEA analysis revealed a striking enrichment of the "Ferroptosis" signaling pathway. Concurrently, MSEA uncovered distinct functional characteristics of metabolic reprogramming; notably, the "pentose phosphate pathway" and "glycerophospholipid metabolism" were significantly downregulated in the inhibitor group. This indicates that cells lose the capacity to repair oxidatively damaged membrane structures through lipid remodeling, thereby critically exacerbating the accumulation of lipid peroxides. (6) Accumulation of divalent iron icons: Inhibitor mice displayed markedly elevated levels of intracellular ROS in CD71+ erythroid cells, along with increased levels of malondialdehyde and Fe²? within the spleen. Furthermore, a distinct iron overload was distinctly evident in the hepatocytes of these inhibitor mice.

Conclusion: FVIII inhibitor mice exhibited marked changes in splenic immune cell subsets,characterized by reduced B cells and macrophages alongside expanded erythroid cells. The activation of cellular ferroptosis, the TF-TFRC iron metabolism pathway, and elevated pro-inflammatory cytokines collectively point to a critical role in the pathogenesis of FVIII inhibitor formation. Our findings hold significant potential as diagnostic and therapeutic targets for HA with inhibitor development.

Yingyu Chen, PhD: No relevant conflicts of interest to declare.